Pricing Log in Create free account

Cassava Sciences, Inc. (FLNA) vs Lite Strategy, Inc. (LITS)

Cassava Sciences, Inc. and Lite Strategy, Inc. are both Biotechnology companies. Cassava Sciences, Inc. and Lite Strategy, Inc. are of similar size ($36.8M and $36.3M). Cassava Sciences, Inc. grew revenue faster over the last twelve months: 277.6% against 152.9%. Across the 10 metrics below, Cassava Sciences, Inc. leads on 7 and Lite Strategy, Inc. on 3.

Valuation

Metric FLNA LITS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.37 9.71
P/B 0.54 0.95 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.08 n/m 0.64
EV/Sales n/m 0.32 9.21
Earnings yield (122.54%) (179.62%) (33.15%)
Free cash flow yield (85.60%) (264.16%) (25.50%)

Profitability

Metric FLNA LITS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (55.78%) (243.02%) (56.36%)
Return on assets (35.34%) (233.37%) (48.04%)
Return on invested capital 0.00% (115.85%) 0.00%

Growth

Metric FLNA LITS Biotechnology median
Revenue growth (TTM) 277.58% 152.90% 6.02%
EPS growth (last fiscal year) (259.95%) 13.86% 30.26%
Revenue growth, 5-year CAGR — 67.75% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLNA LITS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 5.74 4.72
Net debt to EBITDA 1.01 0.09 0.96

Dividend

Metric FLNA LITS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FLNA LITS Biotechnology median
Market cap 36.75m 36.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack